NOVARTIS AG (NVSEF)
Clinical trial NCT04905316 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01
Clinical trial NCT04905316 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical